Electrocardiography is a graphic record of electrical potentials produced by cardiac tissue. An electrographic tracing is created when electrical impulses produced by the heart spread to the body surface where they are detected by electrodes connected to a recording device. The ECG specifically addressed in this LCD is the standard 12-lead ECG, with or without a rhythm strip or other special leads. A qualified physician or NPP who is licensed by his state to perform these services must make an interpretation. The recording and interpretation should be part of the patient’s medical record.
The ECG is valuable in the evaluation and management of primary diseases of the heart, pericardium and coronary arteries. Electrocardiography may be useful in management of diseases that are not primarily cardiac but which frequently affect the heart either directly or indirectly. The following are indications for which the ECG is appropriate:
- Cardiac ischemia or infarction (new symptoms or exacerbations of known disease).
- Anatomic or structural abnormalities of the heart such as congenital, valvular or hypertrophic heart disease.
- Rhythm disturbances and conduction system disease.
- Chest and central nervous system trauma.
- Use of medications or exposure to toxic substances that affect the heart.
- Metabolic abnormalities such as hyper/hypokalemia, hyper/hypocalcemia, hyper/hypothyroidism, acidosis, alkalosis.
- Systemic diseases that involve the heart.
- Evaluation and management related to invasive cardiac procedures.
- Evaluation of implanted electronic cardiac pacemakers.
- Preoperative management of selected patients.
Patients with cardiac ischemia often present with chest pain. Not infrequently, patients with cardiac ischemia present with symptoms (including atypical chest discomfort) that are atypical for, but which may actually represent myocardial ischemia or infarction. The ECG may be utilized in the evaluation of patients with chest pain (typical or atypical) or other symptoms that are atypical but may be due to cardiac ischemia when an alternate explanation for the symptoms is not apparent.
Whereas there is no argument that the ECG is an important diagnostic tool, coverage cannot be provided for ECGs performed when there is no clear relationship to treatment or diagnosis of a specific disease or injury, or a sign, symptom or complaint is apparent. Payment for the services affected by this LCD must be made only for those services that directly contribute to the diagnosis and treatment of an individual patient. Services provided that do not directly contribute to the diagnosis or treatment of an individual patient (such as ECGs that are performed routinely upon admission to a facility or routinely performed prior to surgery) are not medically necessary and will be denied when billed and coded appropriately.
Preoperative electrocardiography is an important part of assessment of risk of preoperative cardiac morbidity. Important considerations include patient-specific predictors as well as surgery-specific risks. Medicare coverage of preoperative electrocardiography is limited to those patients who possess one or more patient-specific indicators of increased risk for perioperative cardiac morbidity and who will undergo surgery of high or intermediate risk of cardiac morbidity/mortality. Preoperative ECGs performed in circumstances other than those listed above are considered screening and should be billed accordingly.
Patient-specific predictors are such things as age, absence or presence of cardiac disease or dysfunction, current and recent stability of cardiac symptoms and syndromes, and the absence or presence of comorbid conditions known to increase the risk that undisclosed cardiac disease is present. Surgery-specific risks relate to the type of surgery and its associated degree of hemodynamic stress. High-risk procedures include major emergency surgery, aortic and major vascular surgeries, peripheral vascular surgery and prolonged procedures associated with large fluid shifts or blood loss. Intermediate-risk procedures include carotid endarterectomy, prostate surgery, orthopedic procedures, head and neck procedures, intraperitoneal and intrathoracic surgery. Low-risk procedures include endoscopy, superficial procedures, cataract surgery and breast surgery.
Medicare generally does not cover screening for heart disease. Though performance of a baseline ECG in certain asymptomatic patients is considered by many to be appropriate and standard medical practice, Medicare, by statute, may pay for such an ECG only as part of the one-time “Welcome to Medicare” preventative physical examination afforded by section 611 of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003. All other electrocardiography performed on asymptomatic individuals is considered screening regardless of the presence of risk factors (for cardiac disease) such as family history, hypertension, diabetes mellitus, hyperlipidemia or advanced age in circumstances where information obtained from the electrocardiogram does not directly affect management of the underlying disease.
Generally, one interpretation should be paid per ECG tracing. ECG interpretations (including “over-readings”) that are not made contemporaneous to patient care and/or that do not directly contribute to the diagnosis and treatment of the individual patient are not covered and should not be billed to Medicare. Examples of such non-covered over-reading services include those that are performed by a physician whether or not that physician is treating the patient in such a manner that the interpretation is unavailable to the treating physician timely for use in decision-making regarding patient care (i.e., interpretations of preoperative tracings that are not available to the surgeon prior to the procedure and interpretations of tracings performed during an Evaluation and Management (E/M) service prompted by acute symptoms that are not available until after the medical decision-making is complete).
Notice: This LCD imposes diagnosis limitations that support diagnosis to procedure code automated denials. However, services performed for any given diagnosis must meet all of the indications and limitations stated in this policy, the general requirements for medical necessity as stated in CMS payment policy manuals, any and all existing CMS national coverage determinations, and all Medicare payment rules.
As published in CMS IOM 100-08, Section 13.5.1, to be covered under Medicare, a service shall be reasonable and necessary. When appropriate, contractors shall describe the circumstances under which the proposed LCD for the service is considered reasonable and necessary under Section 1862(a)(1)(A). Contractors shall consider a service to be reasonable and necessary if the contractor determines that the service is:
- Safe and effective.
- Not experimental or investigational (exception: routine costs of qualifying clinical trial services with dates of service on or after September 19, 2000, which meet the requirements of the clinical trials NCD are considered reasonable and necessary).
- Appropriate, including the duration and frequency that is considered appropriate for the service, in terms of whether it is:
- Furnished in accordance with accepted standards of medical practice for the diagnosis or treatment of the patient’s condition or to improve the function of a malformed body member.
- Furnished in a setting appropriate to the patient’s medical needs and condition.
- Ordered and furnished by qualified personnel.
- One that meets, but does not exceed, the patient’s medical need.
- At least as beneficial as an existing and available medically appropriate alternative.
Bill Type Codes
Contractors may specify Bill Types to help providers identify those Bill Types typically used to report this service. Absence of a Bill Type does not guarantee that the policy does not apply to that Bill Type. Complete absence of all Bill Types indicates that coverage is not influenced by Bill Type and the policy should be assumed to apply equally to all claims.
12X, 13X, 18X, 21X, 22X, 23X, 71X, 75X, 83X, 85X
Revenue Codes
Contractors may specify Revenue Codes to help providers identify those Revenue Codes typically used to report this service. In most instances Revenue Codes are purely advisory; unless specified in the policy services reported under other Revenue Codes are equally subject to this coverage determination. Complete absence of all Revenue Codes indicates that coverage is not influenced by Revenue Code and the policy should be assumed to apply equally to all Revenue Codes.
Note: TrailBlazer has identified the Bill Type and Revenue Codes applicable for use with the CPT/HCPCS codes included in this LCD. Providers are reminded that not all CPT/HCPCS codes listed can be billed with all Bill Type and/or Revenue Codes listed. CPT/HCPCS codes are required to be billed with specific Bill Type and Revenue Codes. Providers are encouraged to refer to the CMS Internet-Only Manual (IOM) Pub. 100-04, Claims Processing Manual, for further guidance.
073X
CPT/HCPCS Codes
Note: | Providers are reminded to refer to the long descriptors of the CPT codes in their CPT book. The American Medical Association (AMA) and the Centers for Medicare & Medicaid Services (CMS) require the use of short CPT descriptors in policies published on the Web. |
93000© | Electrocardiogram, complete |
93005© | Electrocardiogram, tracing |
93010© | Electrocardiogram report |
ICD-9-CM Codes That Support Medical Necessity
The CPT/HCPCS codes included in this LCD will be subjected to “procedure to diagnosis” editing. The following lists include only those diagnoses for which the identified CPT/HCPCS procedures are covered. If a covered diagnosis is not on the claim, the edit will automatically deny the service as not medically necessary.
Medicare is establishing the following limited coverage for CPT/HCPCS codes 93000, 93005 and 93010:
Covered for:
002.0 | Typhoid fever |
005.1 | Botulism |
017.90–017.96 | Tuberculosis of other specified organs |
018.00–018.06 | Acute miliary tuberculosis |
018.80–018.86 | Other specified miliary tuberculosis |
018.90–018.96 | Miliary tuberculosis unspecified |
020.2 | Septicemic plague |
022.3 | Anthrax septicemia |
032.82 | Diphtheritic myocarditis |
036.2 | Meningococcemia |
036.40–036.43 | Meningococcal carditis |
038.0 | Streptococcal septicemia |
038.10–038.11 | Staphylococcal septicemia |
038.19 | Other staphylococcal septicemia |
038.2–038.3 | Septicemia |
038.40–038.44 | Septicemia due to other gram-negative organisms |
038.8–038.9 | Septicemia |
040.0 | Gas gangrene |
042 | Human immunodeficiency virus (HIV) disease |
054.5 | Herpetic septicemia |
074.21–074.23 | Coxsackie carditis |
086.0 | Chagas' disease with heart involvement |
088.81 | Lyme disease |
093.0–093.1 | Cardiovascular syphilis |
093.20–093.24 | Syphilitic endocarditis |
093.81–093.82 | Other specified cardiovascular syphilis |
093.89 | Other specified cardiovascular syphilis |
093.9 | Cardiovascular syphilism unspecified |
098.83–098.85 | Gonococcal infection of other specified sites |
112.5 | Disseminated candidiasis |
112.81 | Candidal endocarditis |
115.03–115.04 | Histoplasmosis |
115.13–115.14 | Histoplasma duboisii |
115.93–115.94 | Histoplasmosis, unspecified |
124 | Trichinosis |
130.3 | Myocarditis due to toxoplasmosis |
130.8 | Multisystemic disseminated toxoplasmosis |
135 | Sarcoidosis |
163.0–163.1 | Malignant neoplasm of parietal pleura |
163.8–163.9 | Malignant neoplasm of pleura |
164.0–164.9 | Malignant neoplasm of thymus, heart, and mediastinum |
165.0 | Malignant neoplasm of upper respiratory tract part unspecified |
165.8–165.9 | Malignant neoplasm of other and ill-defined sites within the respiratory system and intrathoracic organs |
212.4–212.7 | Benign neoplasm of respiratory and intrathoracic organs |
242.00–242.01 | Toxic diffuse goiter |
242.10–242.11 | Toxic uninodular goiter |
242.20–242.21 | Toxic multinodular goiter |
242.30–242.31 | Toxic nodular goiter unspecified |
242.40–242.41 | Thyrotoxicosis from ectopic thyroid nodule |
242.80–242.81 | Thyrotoxicosis of other specified origin |
242.90–242.91 | Thyrotoxicosis without mention of goiter or other cause |
243 | Congenital hypothyroidism |
244.0–244.3 | Postsurgical hypothyroidism |
244.8–244.9 | Acquired hypothyroidism |
245.0–245.4 | Acute thyroiditis |
245.8–245.9 | Thyroiditis |
250.10–250.13 | Diabetes with ketoacidosis |
250.20–250.23 | Diabetes with hyperosmolarity |
250.30–250.33 | Diabetes with other coma |
250.40–250.43 | Diabetes with renal manifestations |
250.50–250.53 | Diabetes with ophthalmic manifestations |
250.60–250.63 | Diabetes with neurological manifestations |
250.70–250.73 | Diabetes with peripheral circulatory disorders |
250.80–250.83 | Diabetes with other specified manifestations |
250.90–250.93 | Diabetes with unspecified complication |
251.0 | Hypoglycemic coma |
252.00–252.02 | Hyperparathyroidism |
252.08 | Other Hyperparathyroidism |
252.1 | Hypoparathyroidism |
252.8–252.9 | Disorders of the parathyroid gland |
255.0 | Cushing’s syndrome |
255.10–255.14 | Hyperaldosteronism |
255.2–255.3 | Disorders of adrenal glands |
255.41-255.42 | Corticoadrenal insufficiency |
255.5-255.6 | Disorders of adrenal glands |
255.8–255.9 | Disorders of adrenal glands |
265.0– 265.2 | Beriberi - pellagra |
270.0 | Disturbances of amino-acid transport |
272.0–272.9 | Disorders of lipoid metabolism |
274.82 | Gouty tophi of other sites except ear |
275.2–275.3 | Disorders of mineral metabolism |
275.41–275.42 | Disorders of calcium metabolism |
275.49 | Other disorders of calcium metabolis |
276.0–276.4 | Disorders of fluid, electrolyte, and acid-base balance |
276.52 | Hypovolemia |
276.69 | Other fluid overload |
276.7–276.9 | Disorders of fluid, electrolyte, and acid-base balance |
277.30 | Amyloidosis |
277.39 | Other amyloidosis |
277.5 | Mucopolysaccharidosis |
282.60–282.64 | Sickle-cell disease |
282.68–282.69 | Sickle-cell disease |
293.0 | Delirium due to conditions classified elsewhere |
306.2 | Cardiovascular malfunction arising from mental factors |
337.00–337.01 | Disorders of the autonomic nervous system |
337.09 | Other idiopathic peripheral autonomic neuropathy |
357.6 | Polyneuropathy due to drugs |
362.30–362.37 | Retinal vascular occlusion |
390 | Rheumatic fever without mention of heart involvement |
391.0–391.2 | Acute rheumatic endocarditis |
391.8–391.9 | Acute rheumatic endocarditis |
392.0 | Rheumatic chorea with heart involvement |
392.9 | Rheumatic chorea without heart involvement |
393 | Chronic rheumatic pericarditis |
394.0–394.2 | Diseases of mitral valve |
394.9 | Diseases of mitral valve, other and unspecified |
395.0–395.2 | Diseases of aortic valve |
395.9 | Diseases of aortic valve, other and unspecified |
396.0–396.3 | Diseases of mitral and aortic valves |
396.8–396.9 | Diseases of mitral and aortic valves |
397.0–397.1 | Diseases of other endocardial structures |
397.9 | Rheumatic diseases of endocardium, valve unspecified |
398.0 | Rheumatic myocarditis |
398.90–398.91 | Other rheumatic heart diseases |
398.99 | Other rheumatic heart diseases |
401.0–401.1 | Essential hypertension |
401.9 | Essential hypertension, unspecified |
402.00–402.01 | Hypertensive heart disease, malignant |
402.10–402.11 | Hypertensive heart disease, benign |
402.90–402.91 | Hypertensive heart disease, unspecified |
403.00–403.01 | Hypertensive renal disease, malignant |
403.10–403.11 | Hypertensive renal disease, benign |
403.90–403.91 | Hypertensive renal disease, unspecified |
404.00–404.03 | Hypertensive heart and renal disease, malignant |
404.10–404.13 | Hypertensive heart and renal disease, benign |
404.90–404.93 | Hypertensive heart and renal disease, unspecified |
405.01 | Secondary hypertension, malignant, renovascular |
405.09 | Other malignant secondary hypertension |
405.11 | Benign renovascular hypertension |
405.19 | Other benign secondary hypertension |
405.91 | Unspecified renovascular hypertension |
405.99 | Other unspecified secondary hypertension |
410.00–410.02 | Acute myocardial infarction, of anterolateral wall |
410.10–410.12 | Acute myocardial infarction, of other anterior wall |
410.20–410.22 | Acute myocardial infarction, of inferolateral wall |
410.30–410.32 | Acute myocardial infarction, of inferoposterior wall |
410.40–410.42 | Acute myocardial infarction, of other inferior wall |
410.50–410.52 | Acute myocardial infarction, of other lateral wall |
410.60–410.62 | Acute myocardial infarction, true posterior wall |
410.70–410.72 | Acute myocardial infarction, subendocardial |
410.80–410.82 | Acute myocardial infarction, of other specified sites |
410.90–410.92 | Acute myocardial infarction, unspecified site |
411.0–411.1 | Other acute and subacute forms of ischemic heart disease |
411.81 | Acute coronary occlusion without myocardial infarction |
411.89 | Other acute and subacute forms of ischemic heart disease |
412 | Old myocardial infarction |
413.0–413.1 | Angina pectoris |
413.9 | Other and unspecified angina pectoris |
414.00–414.07 | Coronary atherosclerosis |
414.10–414.12 | Aneurysm and dissection of heart |
414.19 | Aneurysm of heart, other |
414.2–414.3 | Other forms of chronic ischemic heart disease |
414.8–414.9 | Other forms of chronic ischemic heart disease |
415.0 | Acute cor pulmonale |
415.11–415.12 | Pulmonary embolism and infarction |
415.19 | Other pulmonary embolism and infarction |
416.0–416.2 | Chronic pulmonary heart disease |
416.8–416.9 | Chronic pulmonary heart disease |
417.0–417.1 | Other diseases of pulmonary circulation |
417.8–417.9 | Other diseases of pulmonary circulation |
420.0 | Acute pericarditis in diseases classified elsewhere |
420.90–420.91 | Other and unspecified acute pericarditis |
420.99 | Other acute pericarditis |
421.0–421.1 | Acute and subacute endocarditis |
421.9 | Acute endocarditis, unspecified |
422.0 | Acute myocarditis in diseases classified elsewhere |
422.90–422.93 | Acute myocarditis |
422.99 | Other acute myocarditis |
423.0–423.3 | Other diseases of pericardium |
423.8–423.9 | Other diseases of pericardium |
424.0–424.3 | Other diseases of endocardium |
424.90–424.91 | Other diseases of endocardium |
424.99 | Other endocarditis valve unspecified |
425.0–425.5 | Cardiomyopathy |
425.7–425.9 | Cardiomyopathy |
426.0 | Atrioventricular block, complete |
426.10–426.13 | Atrioventricular block, other and unspecified |
426.2–426.4 | Conduction disorders |
426.50–426.54 | Bundle branch block, other and unspecified |
426.6–426.7 | Conduction disorders |
426.81–426.82 | Other specified conduction disorders |
426.89 | Other specified conduction disorders, other |
426.9 | Conduction disorder, unspecified |
427.0–427.2 | Cardiac dysrhythmias |
427.31–427.32 | Atrial fibrillation and flutter |
427.41–427.42 | Ventricular fibrillation and flutter |
427.5 | Cardiac arrest |
427.60–427.61 | Premature beats |
427.69 | Premature beats, other |
427.81 | Sinoatrial node dysfunction |
427.89 | Sinoatrial node dysfunction, other |
427.9 | Cardiac dysrhythmias, unspecified |
428.0–428.1 | Heart failure |
428.20–428.23 | Systolic heart failure |
428.30–428.33 | Diastolic heart failure |
428.40–428.43 | Combined systolic and diastolic heart failure |
428.9 | Heart failure, unspecified |
429.0–429.6 | Ill-defined descriptions and complications of heart disease |
429.71 | Acquired cardiac septal defect |
429.79 | Certain sequelae of myocardial infarction, NEC, other |
429.81–429.83 | Other ill-defined heart disease |
429.89 | Other ill-defined heart disease |
429.9 | Heart disease, unspecified |
430 | Subarachnoid hemorrhage |
431 | Intracerebral hemorrhage |
432.0–432.1 | Other and unspecified intracranial hemorrhage |
432.9 | Unspecified intracranial hemorrhage |
433.00–433.01 | Occlusion and stenosis of precerebral arteries, basilar artery |
433.11 | Occlusion and stenosis of carotid artery with cerebral infarction |
433.21 | Occlusion and stenosis of vertebral artery with cerebral infarction |
433.31 | Occlusion and stenosis of multiple and bilateral precerebral arteries with cerebral infarction |
433.81 | Occlusion and stenosis of other specified precerebral artery with cerebral infarction |
433.91 | Occlusion and stenosis of unspecified precerebral artery with cerebral infarction |
434.00–434.01 | Occlusion of cerebral arteries, cerebral thrombosis |
434.10–434.11 | Occlusion of cerebral arteries, cerebral embolism |
434.90–434.91 | Cerebral artery occlusion, unspecified |
435.0–435.3 | Transient cerebral ischemia |
435.8–435.9 | Transient cerebral ischemia |
436 | Acute but ill-defined cerebrovascular disease |
437.0–437.9 | Cerebral atherosclerosis |
440.9 | Generalized and unspecified atherosclerosis |
441.00–441.03 | Dissection of aorta |
441.1–441.7 | Aortic aneurysm and dissection |
441.9 | Aortic aneurysm of unspecified site without rupture |
442.89 | Aneurysm of other specified site |
443.0–443.1 | Other peripheral vascular disease |
443.21–443.24 | Other arterial dissection |
443.29 | Dissection of other artery |
443.81–443.82 | Other specified peripherial vascular diseases |
443.89 | Other peripherial vascular diseases |
443.9 | Peripherial vascular disease, unspecified |
444.0–444.1 | Arterial embolism and thrombosis |
444.21–444.22 | Arterial embolism and thrombosis, of arteries of the extremities |
444.81 | Embolism and thrombosis of iliac artery |
444.89 | Embolism and thrombosis of other artery |
444.9 | Embolism and thrombosis of unspecified artery |
446.0–446.1 | Polyarteritis nodosa and allied conditions |
446.20–446.21 | Hypersensitivity angiitis |
446.29 | Other specified Hypersensitivity angiitis |
446.3 –446.7 | Polyarteritis nodosa and allied conditions |
458.0–458.1 | Orthostatic hypotension |
458.21 | Hypotension of hemodialysis |
458.29 | Other iatrogenic hypotension |
458.8–458.9 | Hypotension |
491.20–491.22 | Obstructive chronic bronchitis |
492.0 | Emphysematous bleb |
492.8 | Other emphysema |
493.00–493.02 | Extrinsic asthma |
493.10–493.12 | Intrinsic asthma |
493.20–493.22 | Chronic obstructive asthma |
493.81–493.82 | Other forms of asthma |
493.90–493.92 | Asthma unspecified |
496 | Chronic airway obstruction not elsewhere classified |
506.1 | Acute pulmonary edema due to fumes and vapors |
507.0 | Pneumonitis due to inhalation of food or vomitus |
511.0–511.1 | Pleurisy |
511.81 | Malignant pleural effusion |
511.9 | Unspecified pleural effusion |
514 | Pulmonary congestion and hypostasis |
518.2 | Compensatory emphysema |
518.4–518.5 | Other diseases of lung |
518.7 | Transfusion related acute lung injury |
518.81–518.84 | Other diseases of lung |
519.3 | Other diseases of mediastinum not else where classified |
530.0 | Achalasia and cardiospasm |
530.10–530.13 | Esophagitis |
530.19 | Other esophagitis |
530.20–530.21 | Ulcer of esophagus |
530.3–530.5 | Diseases of esophagus |
530.81 | Esophageal reflux |
530.86–530.87 | Other specified disorders of esophagus |
552.3 | Diaphragmatic hernia with obstruction |
557.0 | Acute vascular insufficiency of intestine |
569.85 | Angiodysplasia of intestine with hemorrhage |
577.0 | Acute pancreatitis |
580.0 | Acute glomerulonephritis with lesion of proliferative glomerulonephritis |
580.4 | Acute glomerulonephritis with lesion of rapidly progressive glomerulonephritis |
585.3–585.6 | Chronic kidney disease |
611.71 | Mastodynia |
634.50–634.52 | Abortion complicated by shock |
634.60–634.62 | Abortion complicated by embolism |
635.50–635.52 | Legally induced abortion complicated by shock |
635.60–635.62 | Legally induced abortion complicated by embolism |
636.50–636.52 | Illegally induced abortion complicated by shock |
636.60–636.62 | Illegally induced abortion complicated by embolism |
637.50–637.52 | Unspecified abortion complicated by shock |
637.60–637.62 | Unspecified abortion complicated by embolism |
638.5–638.6 | Failed attempted abortion |
639.5–639.6 | Complications following abortion and ectopic and molar pregnancies |
639.8 | Other specified complications following abortion or ectopic and molar pregnancy |
642.00– 642.04 | Benign essential hypertension complicating pregnancy |
642.10–642.14 | Hypertension secondary to renal disease complicating pregnancy |
642.20–642.24 | Other pre-existing hypertension complicating pregnancy |
642.30–642.34 | Transient hypertension of pregnancy |
642.40–642.44 | Mild or unspecified pre-eclampsia |
642.50 – 642.54 | Severe pre-eclampsia |
642.60–642.64 | Eclampsia |
642.70–642.74 | Pre-eclampsia or eclampsia superimposed on pre-existing hypertension |
642.90–642.94 | Unspecified hypertension complicating pregnancy |
648.50–648.54 | Congenital cardiovascular disorders |
648.60–648.64 | Other cardiovascular diseases |
668.00–668.04 | Pulmonary complications |
668.11– 668.14 | Cardiac complications |
669.10–669.14 | Shock during or following labor and delivery |
669.20–669.24 | Maternal hypotension syndrome |
669.40–669.44 | Other complications of obstetrical surgery and procedures |
673.00–673.04 | Obstetrical air embolism |
673.10–673.14 | Amniotic fluid embolism |
673.20–673.24 | Obstetrical blood-clot embolism |
673.30–673.34 | Obstetrical pyemic and septic embolism |
673.80–673.84 | Other and unspecified complications of puerperium, not elsewhere classified |
674.80 | Other complications of puerperium unspecified as to episode of care |
674.82 | Other complications of puerperium with delivery with postpartum complication |
674.84 | Other complications of puerperium |
710.0–710.1 | Systemic lupus erythematosus |
714.0–714.2 | Rheumatoid arthritis and other inflammatory polyarthropathies |
714.30–714.33 | Juvenile chronic polyarthritis |
714.4 | Chronic postrheumatic arthropathy |
714.81 | Rheumatoid lung |
714.89 | Other specified inflammatory polyarthropathies |
714.9 | Unspecified inflammatory polyarthropathy |
719.41–719.43 | Pain in joint |
724.1 | Pain in thoracic spine |
729.5 | Pain in limb |
729.71 | Nontraumatic compartment syndrome of upper extremity |
729.81–729.82 | Other musculoskeletal symptoms referable to limbs |
729.89 | Other musculoskeletal symptoms referable to limbs |
733.6 | Tietze’s disease |
738.3 | Acquired deformity of chest and rib |
745.0 | Common truncus |
745.10–745.12 | Transposition of great vessels |
745.19 | Bulbus cordis anomalies and anomalies of cardiac septal closure, other |
745.2–745.5 | Bulbus cordis anomalies and anomalies of cardiac septal closure |
745.60–745.61 | Endocardial cushion defects |
745.69 | Other endocardial cushion defects |
745.7–745.9 | Bulbus cordis anomalies and anomalies of cardiac septal closure |
746.00–746.02 | Other congenital anomalies of heart |
746.09 | Other congenital anomalies of heart |
746.1–746.7 | Other congenital anomalies of heart |
746.81–746.87 | Other specified anomalies of heart |
746.89 | Other specified anomalies of heart |
746.9 | Unspecified congenital anomaly of heart |
747.0 | Patent ductus arteriosis |
747.10–747.11 | Coartaction of aorta |
747.20–747.22 | Other congenital anomalies of circulatory system |
747.29 | Other anomalies of aorta |
747.3 | Anomalies of pulmonary arteries |
747.40–747.42 | Anomalies of great veins |
747.49 | Other anomalies of great veins |
754.81–754.82 | Other specified nonteratogenic anomalies |
780.01–780.03 | Alteration of consciousness |
780.09 | Alteration of consciousness; other |
780.1–780.2 | General symptoms |
780.31–780.33 | Convulsions |
780.39 | Other convulsions |
780.4 | Dizziness and giddiness |
780.50–780.59 | Sleep disruptions |
780.60–780.61 | Fever |
780.71 | Chronic fatigue syndrome |
780.79 | Other malaise and fatigue |
782.0 | Disturbance of skin sensation |
782.3 | Edema |
782.5 | Cyanosis |
782.61–782.62 | Pallor and flushing |
784.1 | Throat pain |
784.92 | Jaw pain |
785.0–785.4 | Symptoms involving cardiovascular system |
785.50–785.52 | Symptoms involving cardiovascular system, shock without mention of trauma |
785.59 | Other shock without trauma |
785.6 | Enlargement of lymph nodes |
785.9 | Other symptoms involving cardiovascular system |
786.00–786.07 | Dyspnea and respiratory abnormalities |
786.09 | Other dyspnea and respiratory abnormalities |
786.50–786.52 | Other symptoms involving cardiovascular system |
786.59 | Other chest pain |
787.01–787.03 | Nausea and vomiting |
787.1 | Heartburn |
789.00–789.07 | Abdominal pain |
789.09 | Abdominal pain other specified site |
789.1 | Hepatomegaly |
790.4 | Nonspecific elevation of levels of transaminase or lactic acid dehydrogenase (ldh) |
793.1–793.2 | Nonspecific abnormal findings on radiological and other examinations, lung field |
794.30–794.31 | Nonspecific abnormal results of function tests, cardiovascular |
794.39 | Nonspecific abnormal results of function tests, cardiovascular other |
796.3 | Nonspecific low blood pressure reading |
799.01–799.02 | Asphyxia and hypoxemia |
799.1 | Respiratory arrest |
807.00–807.09 | Rib(s) closed |
807.11–807.19 | Rib(s) opened |
807.2–807.4 | Fracture of rib(s), sternum, larynx, and trachea |
860.0–860.5 | Traumatic pneumothorax and hemothorax |
861.00–861.03 | Injury to heart without mention of open wound into thorax |
861.10–861.13 | Injury to heart with open wound into thorax |
861.20–861.22 | Lung, without mention of open wound into thorax |
861.30–861.32 | Lung, with open wound into thorax |
862.0 | Diaphragm, without mention of open wound into cavity |
862.21–862.22 | Other specified intrathoracic organs, without mention of open wound into cavity |
862.29 | Other specified intrathoracic organs, without mention of open wound into cavity |
862.31–862.32 | Other specified intrathoracic organs with open wound into cavity |
862.39 | Other specified intrathoracic organs with open wound into cavity |
862.8–862.9 | Injury to multiple and unspecified intrathoracic organs |
875.0–875.1 | Open wound of chest (wall) |
901.0–901.3 | Injury to blood vessels of thorax |
901.40–901.42 | Injury to pulmonary blood vessels |
901.81–901.83 | Injury to other specified blood vessels of thorax |
901.89 | Injury to other specified blood vessels of thorax |
922.1 | Contusion of chest wall |
926.8–926.9 | Crushing injury to trunk |
958.0–958.1 | Certain early complications of trauma |
958.4 | Traumatic shock |
959.11–959.12 | Injury, other and unspecified, trunk |
959.19 | Other injury of other sites of trunk |
972.0–972.9 | Poisoning by agents primarily affecting the cardiovascular system |
986 | Toxic effect of carbon monoxide |
989.3–989.5 | Toxic effect of other substances, chiefly non-medicinal as to source |
991.6 | Hypothermia |
992.0–992.1 | Effects of heat and light |
993.2–993.4 | Effects of air pressure |
994.0–994.1 | Effects of other external causes |
994.4–994.5 | Effects of other external causes |
994.7–994.8 | Effects of other external causes |
995.0 | Other anaphylactic shock |
995.4 | Shock due to anesthesia |
995.60–995.69 | Anaphylactic shock due to adverse food reaction |
996.00–996.04 | Complications peculiar to certain specified procedures |
996.09 | Mechanical complication of other device, implant, and graft |
996.1 | Mechanical complication of other vascular device implant and graft |
996.61 | Infection and inflammatory reaction due to cardiac device, implant, and graft |
996.71–996.72 | Other complications of internal (biological)(synthetic) prosthetic device, implant and graft |
996.83–996.84 | Complications of transplanted organ |
997.1–997.2 | Nervous system complications |
997.4 | Digestive system complications not elsewhere classified |
998.0 | Postoperative shock, not elsewhere classified |
999.1 | Air embolism as a complication of medical care not elsewhere classified |
999.4–999.5 | Complications of medical care not elsewhere classified |
999.9 | Other and unspecified complications of medical care not elsewhere classified |
V12.53 | Personal history of sudden cardiac arrest |
V15.1 | Personal history of surgery to heart and great vessels |
V42.1–V42.2 | Organ or tissue replaced by transplant |
V43.21–V43.22 | Organ or tissue replaced by other means, heart |
V43.3–V43.4 | Organ or tissue replaced by other means |
V45.00–V45.02 | Other post-procedural states |
V45.09 | Cardiac device in situ, other specified cardiac device |
V45.81–V45.82 | Other post-procedural states |
V45.88 | Status post administration of tPA (rtPA) in a different facility within the last 24 hours prior to admission to current facility |
V47.2 | Other cardiorespiratory problems |
V53.31–V53.32 | Fitting and adjustment of other device |
V53.39 | Fitting and adjustment of cardiac device, other |
V58.44 | Aftercare following organ transplant |
V58.69* | Long-term (current) use of other medications (high-risk medications) |
Note: *May be used, even though the high-risk medication has not been started (is not current). | |
V67.51 | Follow-up examination following completed treatment with high-risk medication not elsewhere classified |
V69.4 | Lack of adequate sleep |
V72.81*–V72.84* | Special investigations and examinations |
Note: *When billing one of these codes, you must also include other ICD-9-CM codes for the medical condition(s) that prompted the surgery or preoperative medical evaluation. The use of these diagnosis codes alone does not establish medical necessity and claims will be denied. |
Note: Providers should continue to submit ICD-9-CM diagnosis codes without decimals on their claim forms and electronic claims.
Diagnoses That Support Medical Necessity
One of the following “E” codes may be used as a secondary diagnosis when one of the above ICD-9-CM diagnosis codes is used as the primary diagnosis.
E925.0 | Accident caused by domestic wiring and appliances |
E925.1 | Accident caused by electric current in electric power generating plants distribution stations transmission lines |
E925.2 | Accident caused by industrial wiring appliances and electrical machinery |
E925.8 | Accident caused by other electric current |
E925.9 | Accident caused by unspecified electric current |
Note: Use of one of the “E” codes provides further clarification of the need for the procedure but does not affect coverage.
ICD-9-CM Codes That DO NOT Support Medical Necessity
N/A
Diagnoses That DO NOT Support Medical Necessity
All diagnoses not listed in the “ICD-9-CM Codes That Support Medical Necessity” section of this LCD.
Documentation Requirements
- Documentation supporting medical necessity should be legible, maintained in the patient’s medical record and made available to Medicare upon request.
- Documentation should demonstrate that services are provided according to all requirements of this LCD. In this respect, the record should demonstrate the following:
- Evidence of recent, past, ongoing or suspected cardiac disease or symptoms.
- For patients in whom the ECG is performed as part of the evaluation of chest pain or symptoms that are atypical for cardiac ischemia, the record must substantiate that the ordering clinician has a valid concern that the etiology of the chest pain or other symptoms is cardiac in origin. Conversely, the record may show that the ECG is being used to exclude cardiac origin for symptoms (including chest pain) for which cardiac origin cannot be excluded by history or physical examination.
- For serial ECGs, information supporting the medical necessity for repeating the studies at the given interval should be present. Sequential ECGs, either short-term for an acute condition or long-term for a chronic condition, are often appropriate. Documentation must demonstrate that the findings of the test affect management of the condition.
- The report of the professional component (the interpretation) for the ECG must be a complete written report that includes relevant findings and appropriate comparisons. The interpretation may appear on the actual tracing or with a progress note or other report of an E/M service when the ECG is performed in conjunction with performance of an E/M service. An interpretation reported in the latter fashion, when billed as a separate service from the E/M service, should contain the same information as a report made upon the tracing itself. A simple notation of “ECG/EKG normal,” without accompanying tracing, will not, in this circumstance, suffice as documentation of a separately payable interpretation.
- Preoperative ECG studies must indicate the underlying cardiac condition or risks, as well as the proposed operation for which cardiac evaluation is being performed. The ECG must be performed reasonably proximate to the proposed surgery to be considered medically necessary.
Appendices
N/A
Utilization Guidelines
Serial ECGs performed over both the short term (as for an acute condition) or over the long term (as for chronic conditions) may be appropriate when performed at a reasonable frequency. However, such ECGs will not be covered by Medicare unless it is clear that the tests are necessary for monitoring an evolving pathologic process for which the therapy will be altered based on the findings of the ECG. The interval between ECGs should be determined by the physician responsible for the patient’s care upon consideration of factors such as natural history and severity of the underlying condition, recent changes in the condition or onset of new symptoms relating to the condition, and/or the specific patient’s historical responses to therapy for his condition.
Notice: This LCD imposes utilization guideline limitations. Despite Medicare’s allowing up to these maximums, each patient’s condition and response to treatment must medically warrant the number of services reported for payment. Medicare requires the medical necessity for each service reported to be clearly demonstrated in the patient’s medical record. Medicare expects that patients will not routinely require the maximum allowable number of services.

1 comments:
Very useful information...
Medicare Delaware
Post a Comment